Real-time enrollment status for this neuroblastoma clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 3:25 AM UTC
| NCT Number | NCT03363373 |
| Recruiting Status | Recruiting |
| Condition | Neuroblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 122 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Y-mAbs Therapeutics |
| Last Updated on CT.gov | February 19, 2026 (Feb 19, 2026) |
As of April 17, 2026: Clinical trial NCT03363373 is currently recruiting participants. This clinical trial study for neuroblastoma is actively seeking new participants at 6 locations across the United States. The study is sponsored by Y-mAbs Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03363373 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03363373 was last updated Feb 19, 2026 (February 19, 2026). HelloStudys verifies this status automatically.